Henricson Erik, Abresch Richard, Han Jay J, Nicorici Alina, Goude Keller Erica, de Bie Evan, McDonald Craig M
Department of Physical Medicine and Rehabilitation, University of California, Davis, Sacramento, California, USA.
PLoS Curr. 2013 Jul 8;5:ecurrents.md.9e17658b007eb79fcd6f723089f79e06. doi: 10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06.
Data is currently lacking anchoring a 30-meter longitudinal change in walking ability by 6-minute walk test (6MWT) in Duchenne muscular dystrophy as a minimal clinically important difference and "clinically meaningful" person-reported outcomes (PROs) at differing levels of ambulatory ability.
We describe correlation between measures, 1-year change in measures, and correlation of 1-year changes between measures for the six-minute walk test (6MWT), 10-meter run/walk velocity, PedsQL and POSNA Pediatric Outcomes Data Collection Instrument (PODCI) in 24 4-12 year old. ambulatory DMD and 36 typical controls, and determine if minimal clinically important differences (MCID) of PROs contribute to different estimates of 6-minute walk distance (6MWD) change at differing levels of ability.
PedsQL total and physical function and PODCI global, transfer/mobility and sports/physical function PROs demonstrated significant differences between DMD and controls (p<0.00001). In DMD, 6MWD and 10-meter run/walk velocity were correlated with PODCI domain scores, with the transfer/mobility scale showing the strongest relationship (r=0.79 and r=0.76). In DMD, 6MWD distance and 10-meter run/walk velocity weakly correlated with PedsQL domain scores. In DMD, 6MWD, 10-meter run/walk velocity, and PODCI global and transfer and basic mobility demonstrated significant one-year change and exceeded the amount of change representing MCID. In DMD, 6MWD change highly correlated with change in PODCI global and PODCI transfer/mobility scores (r=0.76 and r=0.93). PODCI global and PODCI transfer/mobility scales provided the best estimates of 6MWT performance. A "meaningful" 4.5 point change in a low PODCI transfer / basic mobility score of 30 to 34.5 was associated with a 5.6m 6MWD change from 150.3 to 155.9m. At PODCI levels closer to normative levels for healthy controls, the change in 6MWD distance associated with a "meaningful" change in PODCI scores was almost 46m.
At lower levels of function, smaller increases in 6MWD result in meaningful change in quality of life (QoL) instrument scores. At higher levels of function, larger increases may be necessary to achieve the same QoL change score.
目前缺乏数据来确定在杜氏肌营养不良症中,6分钟步行试验(6MWT)所测得的步行能力30米纵向变化作为最小临床重要差异以及在不同步行能力水平下具有“临床意义”的患者报告结局(PROs)。
我们描述了24名4至12岁能行走的杜氏肌营养不良症(DMD)患者和36名典型对照者的6分钟步行试验(6MWT)、10米跑/走速度、儿童生活质量量表(PedsQL)和POSNA儿科结局数据收集工具(PODCI)各项测量指标之间的相关性、测量指标的1年变化以及各测量指标1年变化之间的相关性,并确定PROs的最小临床重要差异(MCID)是否有助于在不同能力水平下对6分钟步行距离(6MWD)变化进行不同估计。
DMD患者与对照组在PedsQL总分及身体功能、PODCI总体、转移/活动能力和运动/身体功能PROs方面存在显著差异(p<0.00001)。在DMD患者中,6MWD和10米跑/走速度与PODCI各领域得分相关,其中转移/活动能力量表显示出最强的相关性(r=0.79和r=0.76)。在DMD患者中,6MWD距离和10米跑/走速度与PedsQL各领域得分的相关性较弱。在DMD患者中,6MWD、10米跑/走速度以及PODCI总体、转移和基本活动能力均有显著的1年变化,且超过了代表MCID的变化量。在DMD患者中,6MWD变化与PODCI总体和PODCI转移/活动能力得分变化高度相关(r=0.76和r=0.93)。PODCI总体和PODCI转移/活动能力量表对6MWT表现的估计最佳。PODCI转移/基本活动能力得分从低水平的30分有“意义”地提高4.5分至34.5分,与6MWD从150.3米变化至155.9米的5.6米变化相关。在PODCI水平更接近健康对照者的标准水平时,与PODCI得分“有意义”变化相关的6MWD距离变化近46米。
在较低功能水平时,6MWD较小的增加会导致生活质量(QoL)工具得分有意义的变化。在较高功能水平时,可能需要更大的增加才能实现相同的QoL变化得分。